Literature DB >> 3325844

Salidiuretic action of the calcium antagonist nitrendipine in dogs.

K Fukui1, T Tamaki, A Yamamoto, T Shoji, Y Fujisawa, H Iwao, Y Abe.   

Abstract

In an attempt to define the effects of a calcium antagonist, nitrendipine, on renal function, intrarenal hemodynamics, and renin release, we infused the drug into the renal artery of anesthetized dogs. Infusion of nitrendipine at a rate of 5 micrograms/min in both hydropenic and hydrated dogs resulted in a significant increase in renal blood flow (RBF), glomerular filtration rate (GFR), urine flow and renin release, with no change in systemic blood pressure, indicating a significant renal vasodilation. The urinary excretion rate of sodium increased by the same proportion as that of calcium. The intrarenal blood flow as measured by hydrogen washout rate showed that the outer cortical flow increased by the same proportion as the inner cortical flow. During nitrendipine infusion, free water reabsorption rate (TcH2O) in hydropenic dogs or free water clearance (CH2O) in hydrated dogs increased in proportion to the urine flow. Neither the ratio of TcH2O nor that of CH2O to osmolar clearance changed throughout the experiment. These data suggest that nitrendipine may not inhibit sodium transport in the medullary portion of the ascending limb of Henle and may induce an enhancement of the delivery of sodium to the Henle loop. Thus, nitrendipine exerts its diuretic and natriuretic actions via the alteration of renal hemodynamic and the inhibitory effect on proximal sodium reabsorption.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3325844     DOI: 10.1007/bf00169316

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  20 in total

1.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

2.  Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade.

Authors:  K Aoki; S Kondo; A Mochizuki; T Yoshida; S Kato; K Kato; K Takikawa
Journal:  Am Heart J       Date:  1978-08       Impact factor: 4.749

3.  Antihypertensive and renal effects of orally administered verapamil.

Authors:  G Leonetti; C Sala; C Bianchini; L Terzoli; A Zanchetti
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

4.  Nitrendipine increases sodium excretion in acutely saline-loaded rats.

Authors:  B Garthoff; A Knorr; G Thomas; S Kazda
Journal:  Biochem Pharmacol       Date:  1982-09-15       Impact factor: 5.858

5.  Control of renin secretion by Ca2+ and cyclic AMP through two parallel mechanisms.

Authors:  C S Park; D H Sigmon; D S Han; T W Honeyman; J C Fray
Journal:  Am J Physiol       Date:  1986-09

6.  Treatment of hypertension with nifedipine, a calcium antagonistic agent.

Authors:  M T Olivari; C Bartorelli; A Polese; C Fiorentini; P Moruzzi; M D Guazzi
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

7.  Pharmacological studies of the antihypertensive effect of nitrendipine.

Authors:  K Stoepel; A Heise; S Kazda
Journal:  Arzneimittelforschung       Date:  1981

8.  Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.

Authors:  S Kazda; B Garthoff; A Knorr
Journal:  Fed Proc       Date:  1983-02

9.  Effects of EDTA and verapamil on renin release in dogs.

Authors:  Y Abe; T Yukimura; H Iwao; N Mori; T Okahara; K Yamamoto
Journal:  Jpn J Pharmacol       Date:  1983-06

10.  Factors involved in the antihypertensive action of calcium antagonists.

Authors:  B Garthoff; S Kazda; A Knorr; G Thomas
Journal:  Hypertension       Date:  1983 Jul-Aug       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.